Human CD34


Journal

Cellular and molecular life sciences : CMLS
ISSN: 1420-9071
Titre abrégé: Cell Mol Life Sci
Pays: Switzerland
ID NLM: 9705402

Informations de publication

Date de publication:
20 Sep 2023
Historique:
received: 29 05 2023
accepted: 11 08 2023
revised: 26 07 2023
medline: 21 9 2023
pubmed: 20 9 2023
entrez: 20 9 2023
Statut: epublish

Résumé

Allogeneic stem cell transplantation (alloSCT) can be curative for hemato-oncology patients due to effective graft-versus-tumor immunity. However, relapse remains the major cause of treatment failure, emphasizing the need for adjuvant immunotherapies. In this regard, post-transplantation dendritic cell (DC) vaccination is a highly interesting strategy to boost graft-versus-tumor responses. Previously, we developed a clinically applicable protocol for simultaneous large-scale generation of end-stage blood DC subsets from donor-derived CD34

Identifiants

pubmed: 37728691
doi: 10.1007/s00018-023-04923-4
pii: 10.1007/s00018-023-04923-4
pmc: PMC10511603
doi:

Substances chimiques

Interleukin-12 187348-17-0
Antigens, CD34 0
Cell Adhesion Molecules 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

298

Subventions

Organisme : KWF Kankerbestrijding
ID : 10351

Informations de copyright

© 2023. The Author(s).

Références

Clin Cancer Res. 2016 May 1;22(9):2155-66
pubmed: 26712687
Nat Commun. 2020 Aug 24;11(1):4227
pubmed: 32839441
J Clin Invest. 2008 Mar;118(3):1165-75
pubmed: 18259609
Biol Blood Marrow Transplant. 2014 Jan;20(1):4-13
pubmed: 24018392
Cancer Res. 2013 Feb 1;73(3):1063-75
pubmed: 23345163
Nature. 2016 Jun 01;534(7607):396-401
pubmed: 27281205
Int Immunol. 1998 Nov;10(11):1593-8
pubmed: 9846688
Cell Res. 2017 Jan;27(1):74-95
pubmed: 28025976
Immunity. 2017 Feb 21;46(2):205-219
pubmed: 28190711
Front Immunol. 2019 Feb 12;10:9
pubmed: 30809220
Blood. 2018 Jan 11;131(2):202-214
pubmed: 29138222
Biol Blood Marrow Transplant. 2009 Jul;15(7):765-76
pubmed: 19539207
Proc Natl Acad Sci U S A. 2020 Sep 22;117(38):23730-23741
pubmed: 32879009
Cell. 2019 Apr 18;177(3):556-571.e16
pubmed: 30955881
Arterioscler Thromb Vasc Biol. 2019 Jul;39(7):1288-1300
pubmed: 31043076
Cancers (Basel). 2021 May 20;13(10):
pubmed: 34065346
J Exp Med. 2002 Feb 4;195(3):327-33
pubmed: 11828007
Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3012-7
pubmed: 22315415
Immunity. 2010 Dec 14;33(6):955-66
pubmed: 21130004
Front Immunol. 2021 Feb 19;11:631713
pubmed: 33679726
PLoS One. 2016 Jun 09;11(6):e0157175
pubmed: 27280403
Trends Immunol. 2018 Jul;39(7):577-590
pubmed: 29793748
Stem Cells. 2018 Aug;36(8):1138-1145
pubmed: 29658164
Semin Immunol. 2015 Dec;27(6):388-96
pubmed: 27040276
Front Immunol. 2019 Jul 19;10:1719
pubmed: 31379886
Oncoimmunology. 2021 Oct 1;10(1):1981049
pubmed: 34616589
J Exp Med. 2013 Nov 18;210(12):2515-22
pubmed: 24145513
Blood. 2008 Dec 1;112(12):4420-4
pubmed: 18682600
Cell. 2015 Sep 10;162(6):1322-37
pubmed: 26296422
Nat Commun. 2019 Nov 27;10(1):5408
pubmed: 31776331
J Immunother Cancer. 2019 Nov 14;7(1):302
pubmed: 31727154
Oncoimmunology. 2015 Apr 1;4(7):e1017701
pubmed: 26140247
Front Immunol. 2020 Feb 21;11:276
pubmed: 32153583
Cytometry A. 2015 Jul;87(7):636-45
pubmed: 25573116
Methods Mol Biol. 2012;904:37-47
pubmed: 22890920
BMC Genomics. 2016 Nov 7;17(1):880
pubmed: 27821060
Cancer Immunol Immunother. 2017 Oct;66(10):1307-1320
pubmed: 28555259
J Immunol. 2002 Dec 15;169(12):6842-9
pubmed: 12471116
Nat Protoc. 2019 Jul;14(7):1946-1969
pubmed: 31160786
PLoS One. 2012;7(7):e40865
pubmed: 22815848
J Exp Med. 2003 May 5;197(9):1141-51
pubmed: 12732656
Cancer Immunol Res. 2015 May;3(5):495-505
pubmed: 25633713
Biol Blood Marrow Transplant. 2013 Dec;19(12):1661-9
pubmed: 24018393
Leuk Lymphoma. 2001 Nov-Dec;42(6):1351-7
pubmed: 11911419
Front Immunol. 2013 Apr 03;4:82
pubmed: 23565116
Immunology. 2018 May;154(1):3-20
pubmed: 29313948
Cancer Immunol Immunother. 2018 Sep;67(9):1425-1436
pubmed: 30019146
J Immunother Cancer. 2020 Jul;8(2):
pubmed: 32737142
Front Cell Dev Biol. 2020 Jul 03;8:498
pubmed: 32719792
Immunity. 2019 May 21;50(5):1317-1334.e10
pubmed: 30979687
Nat Rev Immunol. 2018 Oct;18(10):635-647
pubmed: 30057419
Blood. 2009 Jul 23;114(4):835-43
pubmed: 19465690
JCI Insight. 2021 Sep 8;6(17):
pubmed: 34283809
Cancer Immunol Immunother. 2021 Nov;70(11):3167-3181
pubmed: 33796917
Cell. 2018 Feb 22;172(5):1022-1037.e14
pubmed: 29429633
Blood. 2009 Mar 12;113(11):2535-46
pubmed: 19139076
J Immunol. 2003 Sep 1;171(5):2366-73
pubmed: 12928383
J Clin Med. 2019 Apr 27;8(5):
pubmed: 31035598

Auteurs

Jesper van Eck van der Sluijs (J)

Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Geert Grooteplein 8, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.

Diede van Ens (D)

Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Geert Grooteplein 8, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.

Jolanda Brummelman (J)

Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Geert Grooteplein 8, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.

Daan Heister (D)

Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Geert Grooteplein 8, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.

Aastha Sareen (A)

Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Geert Grooteplein 8, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.

Lisa Truijen (L)

Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Geert Grooteplein 8, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.

Dorette S van Ingen Schenau (DS)

Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Mirjam H M Heemskerk (MHM)

Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.

Marieke Griffioen (M)

Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.

Michel G D Kester (MGD)

Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.

Nicolaas P M Schaap (NPM)

Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.

Joop H Jansen (JH)

Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Geert Grooteplein 8, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.

Anniek B van der Waart (AB)

Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Geert Grooteplein 8, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.

Harry Dolstra (H)

Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Geert Grooteplein 8, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.

Willemijn Hobo (W)

Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Geert Grooteplein 8, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands. Willemijn.Hobo@Radboudumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH